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Association between vitamin D deficiency
and hypothyroidism: results from the
National Health and Nutrition Examination
Survey (NHANES) 2007–2012
Sandeep Appunni1, Muni Rubens2, Venkataraghavan Ramamoorthy3, Anshul Saxena3, Raees Tonse2,
Emir Veledar3,4,5 and Peter McGranaghan2,3,6*

Abstract
Purpose: Many smaller studies have previously shown a significant association between thyroid autoantibody
induced hypothyroidism and lower serum vitamin D levels. However, these finding have not been confirmed by
large-scale studies. In this study, we evaluated the relationship between hypothyroidism and vitamin D levels using
a large population-based data.
Methods: For this study, we used National Health and Nutrition Examination Survey (NHANES) during the years
2007–2012. We categorized participants into three clinically relevant categories based on vitamin D levels: optimal,
intermediate and deficient. Participants were also split into hypothyroid and hyperthyroid. Weighted multivariable
logistic regression analyses were used to calculate the odds of being hypothyroid based on vitamin D status.
Results: A total of 7943 participants were included in this study, of which 614 (7.7%) were having hypothyroidism.
Nearly 25.6% of hypothyroid patients had vitamin D deficiency, compared to 20.6% among normal controls.
Adjusted logistic regression analyses showed that the odds of developing hypothyroidism were significantly higher
among patients with intermediate (adjusted odds ratio [aOR], 1.7, 95% CI: 1.5–1.8) and deficient levels of vitamin D
(aOR, 1.6, 95% CI: 1.4–1.9).
Conclusion: Low vitamin D levels are associated with autoimmune hypothyroidism. Healthcare initiatives such as
mass vitamin D deficiency screening among at-risk population could significantly decrease the risk for
hypothyroidism in the long-term.
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Introduction
Hypothyroidism is an endocrine disorder characterized
by lower serum levels of thyroxin, resulting in clinical
spectrum that varies from no signs and symptom to life
threatening complications [1, 2]. The major circulating
thyroid hormone consists of thyroxine (Total T4), triiodothyronine (Total T3) and their free forms, free T4
(fT4) and free T3 (fT3) [3]. Blood levels are tightly regulated by the hypothalamus-pituitary-thyroid axis
through a negative feedback mechanism [4].. Classically,
primary overt hypothyroid cases will have low serum
levels of fT4 and reciprocally elevated thyroid stimulating hormone (TSH) [1, 5]. The disease spectrum also
consists of an occult condition known as subclinical
hypothyroidism which is characterized by normal total
T4 levels but modestly elevated TSH [6]. As per
National Health and Nutrition Examination Survey
(NHANES III) of United Sates population (1988 to
1994) the overall prevalence of hypothyroidism is 4.6%
of which 0.3% have overt and 4.3% have subclinical
hypothyroidism [6]. Hypothyroidism due to iodine
deficiency is highly prevalent in geographical regions
where the soil is deficient in iodine, such as hilly and
mountainous terrain, whereas in iodine sufficient areas
autoimmune etiology (Hashimoto’s thyroiditis) predominates [7].
Vitamin D is a fat-soluble nutrient that is canonically
converted in vivo to active hormone (calcitriol or 1,25dihydroxycholecalciferol) following two hydroxylation
steps, first in the liver (calcidiol or 25-hydroxy vitamin
D), and second in the kidneys. Circulating vitamin D status is evaluated by quantitation of serum 25-hydroxy
vitamin D. Vitamin D has two forms. Namely vitamin
D2 and vitamin D3. Vitamin D2 is obtained from plant
sterol ergosterol and vitamin D3 (cholecalciferol) is derived from cholesterol under the skin [8]. Vitamin D is
essential for maintenance of healthy body systems including the immune system and has protective role in
cancer prevention [9]. Vitamin D deficiency is prevalent
in both developed and developing countries and is determined by low serum 25-hydroxy vitamin D (< 25 nmol/l)
levels [10]. In the US, overall vitamin D deficiency prevalence rate was 41.6% and highest in blacks followed by
Hispanics [11].
Hashimoto’s
thyroiditis
is
characterized
by
hemopoietic lymphocytic infiltration and subsequent
autoimmune mediated destruction of the thyroid follicles resulting in variable clinical presentations, ranging
from euthyroid to subclinical to frank hypothyroid state
with or without evident goiter [12]. Different clinicopathological types have been reported and is characterized by circulating antibodies against thyroid peroxidase
(TPO) and thyroglobulin (Tg). TPO is primarily involved
in the synthesis of thyroid hormone (T4 and T3) while
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Tg sequesters thyroid hormones within thyroid follicles
[12, 13]. Epidemiologically, the incidence is more common in females than in males and lower among alcoholics and smokers [14]. Etiopathogenesis involves
genetic predisposition and environmental factor that are
newly associated with vitamin D and selenium deficiency. Vitamin D has immunoregulatory and antiinflammatory functions such as regulating the activity of
the adaptive immune system, especially the low dendritic
cell differentiation, enhanced Th2 helper cells (shifting
from Th1 to Th2 helper cells) maturation, and activation
of T regulatory (Treg) cells [15]. Low vitamin D levels
are significantly correlated with the development of
autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, type 1
diabetes mellitus, multiple sclerosis, and autoimmune
thyroid diseases [16]. A meta-analysis that looked for
vitamin D levels in autoimmune thyroiditis showed that
both Hashimoto thyroiditis and Grave’s disease were associated with lower vitamin D levels [17]. Conversely,
some studies have shown that there was no significant
association between vitamin D and auto immune thyroiditis [18]. In this study, we observed the relationship
between vitamin D and hypothyroidism using a large nationally representative NHANES data.

Methods and materials
Study design

For this study, we used National Health and Nutrition
Examination Survey (NHANES) during the years 2007–
2012. The NHANES is a nationwide survey on the health
and nutritional status of the US population and include all
noninstitutionalized people and is conducted by the National Center for Health Statistics (NCHS), Centers for
Disease Control and Prevention (CDC). NHANES uses
complex, multistage cluster probability sampling design
for conducting the survey and participants are randomly
selected for the survey. Data for the survey are gathered
by conducting interviews of the participants at their
homes, and a selected number of these participants are invited for medical examinations and laboratory evaluations
done at Mobile Examination Centers (MECs). Survey
protocol for NHANES data collection is approved by the
NCHS institutional review board.
Study population

For this study, we used data from participants ≥20 years
of age. All NHANES participants who were ≥ 18 years of
age had signed a written informed consent following an
extensive and detailed description about the survey including the interview, medical examination and laboratory evaluation. Details of the of the methods and
protocols for the questionnaires, laboratory, and examination can be found elsewhere [19].
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Vitamin D status

For this study, we categorized participants into three
clinically relevant categories based on the serum 25(OH)
D levels following the Endocrinology Society Clinical
Practice Guidelines [20]. The three categories are optimal (≥30 ng/mL), intermediate (20 to < 30 ng/mL) and
deficient (< 20 ng/mL) vitamin D levels.
Hypothyroidism

We used the laboratory reference range of thyroid
stimulating hormone (TSH), 0.34–5.60 mIU/L, from
manufacturer’s studies, for diagnosing hypothyroidism
[21]. Participants were defined as hypothyroid if their
TSH was more than 5.60 mIU/L or were on levothyroxine. Participants were categorized as normal controls if
their TSH was between 0.34–5.60 mIU/L and they were
not taking any thyroid medication.
The study was reviewed by the Miami Cancer Institute’s Institutional Review Board, which exempted the
study from institutional review board approval and
waived the requirement for informed consent because it
uses previously collected deidentified data stored in
NHANES.
Statistical analysis

Statistical analysis was performed using SAS (version
9.4, SAS Institute, Cary, North Carolina), which
accounted for the complex survey design and clustering.
Demographic and socioeconomic measures were compared between hypothyroid patients and normal controls
using independent samples t test for continuous variables and Chi-square test for categorical variables. Similarly, clinical characteristics of hypothyroid patients and
normal controls were compared. Weighted multivariable
logistic regression analyses were used to calculate the
odds of being hypothyroid based on vitamin D status,
after adjusting for covariates such as age, education, income, smoking, alcohol consumption, body mass index
(BMI), physical activity, hypertension, diabetes, dyslipidemia, blood urea nitrogen, creatinine and magnesium
levels. The NHANES measures physical activity using
the physical activity questionnaire. Whether the recommended level of physical activity was met (yes or no)
was ascertained through this questionnaire, which included the duration of moderate to vigorous intensity
leisure-time physical activities performed for a minimum
of 10 min at a time in the previous month. Age, race,
education, income, smoking, alcohol consumption, and
physical activity were self-reported by participants during house visits for surveys. Height and weight for BMI,
systolic and diastolic blood pressures, fasting blood glucose, glycated haemoglobin, serum lipid profile, blood
urea nitrogen, creatinine and magnesium levels were
measured by trained healthcare professionals during

Page 3 of 9

Medical Examination Center visits. Since the proportion
of missing data was small and not missing completely on
random, NOMCAR option was used during the regression analysis. Statistical significance was set at P < 0.05.

Results
A total of 7943 participants were included in this study,
of which 614 (7.7%) were having hypothyroidism. The
man age of this cohort was 47.0 (SE = 0.3) years and
51.5% were females. Majority of the participants were
white (69.7%), followed by blacks (10.2%) and Mexican
Americans (8.1%). About 57.5% of the participants had
more than 12 years of formal education. About 37.4% of
participants were in the highest income group and 14.3%
were in the lowest income group. Majority of the participants (80.8%) reported that they had health insurance.
More than half of the participants (58.1%) reported that
they had engaged in some form of physical activity and
75.8% never smoked and 78.1% currently consumed
alcohol. Significant differences were observed in all
demographics and socioeconomic factors between
hypothyroid patients and normal control (Table 1).
Comparison of clinical characteristics between
hypothyroid patients and normal controls also showed
significant difference in majority of the factors. There
was a significant association (P < 0.001) between vitamin
D categories and hypothyroid state (Fig. 1). Nearly 25.6%
of hypothyroid patients had vitamin D deficiency, compared to 20.6% in normal controls. Majority of participants in the hypothyroid group were obese (40.5%),
while 33.4% were obese in the normal controls. Significantly higher proportion of participants in the
hypothyroid group were hypertensive (47.1% versus
29.5%, P < 0.001), diabetic (19.7% versus 10.7%, P <
0.001), and dyslipidemic (54.9% versus 44.7%, P < 0.001).
Similarly, there were significant mean differences in majority of biochemical variables between hypothyroid patients and normal controls. Details are shown in Table 2.
Unadjusted logistic regression analyses or those adjusted for selected covariates (age, sex, race, smoking, alcohol consumption, BMI and physical activity) did not
show any association between vitamin D deficiency and
hypothyroidism. However, logistic regression analyses
adjusted for age, race, education, income, smoking, alcohol consumption, BMI, physical activity, hypertension,
diabetes, dyslipidemia, blood urea nitrogen, creatinine
and magnesium showed that the odds of developing
hypothyroidism were significantly higher among patients
with intermediate (adjusted odds ratio [aOR], 1.7, 95%
CI: 1.5–1.8) and deficient levels of vitamin D (aOR, 1.6,
95% CI: 1.4–1.9). All regression models are shown in
Table 3. Table 4 shows correlation between variables included in the regression models.
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Table 1 Demographic and socioeconomic characteristics of the participants, NHANES 2007–2012 (n = 7943)
Variables

Hypothyroidism
N = 614 (7.7%)

Normal Control
N = 7329 (92.3%)

P value

Total
N = 7943

Age, mean years (SE)

51.2 (0.8)

46. 1 (0.3)

< 0.001

47.0 (0.3)

Female, % (SE)

76.0% (2.4)

49.4% (0.5)

< 0.001

51.5% (0.5)

Race/ethnicity, % (SE)

< 0.001

Non-Hispanic White

86.8% (2.0)

68.2% (2.4)

69.7% (2.3)

Non-Hispanic Black

3.3% (0.6)

10.8% (1.2)

10.2% (1.1)

Mexican American

4.1% (0.9)

8.5% (1.1)

8.1% (1.0)

Other race

5.8% (1.3)

12.5% (1.2)

12% (1.2)

Less than 12

15.2% (2.0)

19.4% (1.1)

19% (1.0)

12

22.9% (2.0)

23.5% (0.8)

23.5% (0.8)

More than 12

62.0% (3.0)

57.1% (1.5)

57.5% (1.5)

< 1 (Lowest income)

7.9% (1.4)

14.9% (0.9)

14.3% (0.9)

1 to < 2

21.6% (1.7)

20.7% (0.9)

20.7% (0.9)

2 to < 4

31.7% (2.3)

27.2% (1.0)

27.5% (1.0)

Education, % (SE)

0.047

FPIR, % (SE)

< 0.001

≥4 (Highest income)

38.7% (3.0)

37.3% (1.5)

Health insurance, % (SE)

92.6% (1.1)

79.8% (0.8)

Physical activity, % (SE)

47.5% (3.7)

59% (0.8)

Smoking, % (SE)

37.4% (1.5)
< 0.001

80.8% (0.8)

0.001

58.1% (0.9)

0.002

Current

13.3% (1.7)

21.8% (0.9)

21.1% (0.8)

Former

2.9% (1.1)

2.9% (0.3)

2.9% (0.3)

Never

83.6% (1.8)

75.1% (0.9)

75.8% (0.8)

Alcohol use, % (SE)
Never

13.9% (1.8)

9.8% (0.6)

Former

12% (1.3)

11.7% (0.6)

11.8% (0.5)

Current

74.1% (2.1)

78.5% (0.8)

78.1% (0.8)

Fig. 1 Comparison of vitamin D categories by hypothyroidism and normal control

0.010

10.1% (0.5)
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Table 2 Clinical characteristics of the participants, NHANES 2007–2012 (N = 7943)
Variables

Hypothyroidism
N = 614

Normal Control
N = 7329

Vitamin D categories, % (SE)

P value

Total
N = 7943

< 0.001

Deficient (< 20 ng/mL)

25.6% (1.9)

20.6% (1.3)

21.0% (1.2)

Intermediate (20 to < 30 g/mL)

38.1% (1.9)

32.7% (0.8)

33.1% (0.7)

Optimal (≥30 ng/mL)

36.3% (1.7)

46.7% (1.2)

BMI (kg/m2), % (SE)

45.9% (1.1)
< 0.001

Underweight (< 18.5 kg/m2)

1.3% (0.6)

1.8% (0.2)

1.7% (0.2)

25.3% (1.6)

30.2% (0.8)

29.8% (0.7)

Overweight (25.0–29.9 kg/m )

33.0% (2.8)

34.2% (0.8)

34.1% (0.8)

Obese (≥30.0 kg/m2)

40.5% (3.0)

33.8% (0.8)

34.4% (0.8)

Hypertension, % (SE)

47.1% (2.9)

29.5% (0.7)

< 0.001

30.9% (0.7)

Diabetes, % (SE)

19.7% (2.4)

10.7% (0.5)

< 0.001

11.5% (0.5)

Normal (18.5–24.9 kg/m2)
2

Dyslipidemia, % (SE)

54.9% (2.3)

44.7% (0.8)

< 0.001

45.5% (0.7)

Thyroglobulin antibodies (IU/mL)

68.1 (3.2)

6.4 (0.8)

< 0.001

11.3 (1.3)

Thyroid peroxidase antibodies (IU/mL)

87.2 (8.6)

15.8 (1.2)

< 0.001

21.3 (1.2)

Total protein (g/L)

70.7 (0.3)

71.3 (0.1)

0.145

71.2 (0.1)

Albumin (g/L)

41.9 (0.2)

42.9 (0.1)

< 0.001

42.8 (0.1)

Alanine aminotransferase (U/L)

25.2 (1.1)

25.9 (0.2)

0.522

25.8 (0.2)

Aspartate aminotransferase (U/L)

27.6 (1.2)

25.9 (0.2)

0.211

26 (0.2)

Alkaline phosphatase (U/L)

68.6 (1.4)

66.7 (0.4)

0.139

66.8 (0.4)

Total bilirubin (mg/dL)

0.74 (0.1)

0.8 (0.1)

0.068

0.8 (0.1)

Iodine, urine (ug/L)

381.7 (63.2)

248.8 (12.6)

0.077

259.5 (13.6)

Direct HDL-Cholesterol (mg/dL)

55 (1.1)

52.2 (0.3)

0.008

52.4 (0.3)

LDL-cholesterol (mg/dL)

117 (1.0)

116.4 (0.6)

0.849

116.4 (0.6)

Total Cholesterol (mg/dL)

198.3 (1.2)

196.9 (0.7)

0.514

197 (0.6)

Triglyceride (mg/dL)

131.8 (2.2)

134 (2.9)

0.710

133.8 (2.6)

Creatinine (mg/dL)

0.88 (0.1)

0.9 (0.01)

0.434

0.9 (0)

Blood urea nitrogen (mg/dL)

14.4 (0.2)

12.9 (0.1)

< 0.001

13 (0.1)

Chloride (mmol/L)

103.3 (0.2)

104 (0.1)

< 0.001

104 (0.1)

Phosphorus (mg/dL)

3.8 (0.1)

3.8 (0.1)

0.002

3.8 (0.1)

Potassium (mmol/L)

4.0 (0.1)

4.0 (0.1)

0.059

4.0 (0.1)

Sodium (mmol/L)

139 (0.1)

139.2 (0.1)

0.226

139.2 (0.1)

Total calcium (mg/dL)

9.4 (0.1)

9.4 (0.2)

0.018

9.4 (0.2)

Discussion
This study evaluated the association between vitamin D
levels and hypothyroidism using a large nationally representative database. Earlier studies on smaller populations
have shown an inverse relationship between vitamin D
levels and the occurrence of hypothyroidism [22–25].
We have studied the association in 7943 participants
who enrolled in the NHANES during the period 2007–
2012 and included 614 hypothyroid participants.
In our study, hypothyroid group had a mean age significantly higher than the control participants and majority of participant cases were females. Similar findings

were found in a study by Mackawy et al. which had
greater number of female subjects with hypothyroidism
[25]. Other studies done in middle income countries
such as India as reported by Velayutham et al. and
Unnikrishnan et al. also had greater number of female
patients with hypothyroidism [26, 27]. This shows that
regular thyroid evaluation of females early in the middle
ages is necessary to diagnose and initiate treatment in
the early course of the illness. Kim et al. observed that
premenopausal females are at a higher risk of developing
autoimmune hypothyroidism compared to men and even
postmenopausal females [28].
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Table 3 Multivariable logistic regression results showing
association between vitamin D and hypothyroidism (N = 7943)
Models

Optimal
(≥30 ng/mL)

Intermediate
(20 to < 30 g/mL)

Deficient
(< 20 ng/mL)

Model 1

Reference

1.4 (0.7–1.6)

1.1 (0.7–1.4)

Model 2

Reference

1.2 (0.7–1.4)

1.3 (0.6–1.7)

Model 3

Reference

1.2 (0.5–1.4)

1.2 (0.4–1.6)

Model 4

Reference

1.3 (0.8–1.5)

1.2 (0.6–1.7)

Model 5

Reference

1.2 (0.7–1.4)

1.3 (0.3–1.7)

Model 6

Reference

1.6 (0.9–1.6)

1.5 (0.3–1.8)

Model 7

Reference

1.7 (1.5–1.8)

1.6 (1.4–1.9)

Model 1: Unadjusted
Model 2: Adjusted for age, sex, education, and income
Model 3: Adjusted for age, sex, education, income, smoking, alcohol
consumption, BMI and physical activity
Model 4: Adjusted for age, education, income, smoking, alcohol consumption,
BMI, physical activity, hypertension, and diabetes
Model 5: Adjusted for age, education, income, smoking, alcohol consumption,
BMI, physical activity, hypertension, diabetes, dyslipidemia, and blood
urea nitrogen
Model 6: Adjusted for age, education, income, smoking, alcohol consumption,
BMI, physical activity, hypertension, diabetes, dyslipidemia, blood urea
nitrogen, and creatinine
Model 7: Adjusted for age, education, income, smoking, alcohol consumption,
BMI, physical activity, hypertension, diabetes, dyslipidemia, blood urea
nitrogen, creatinine, and magnesium

Majority of the hypothyroid subjects in our study were
non-Hispanic whites. Schectman et al. studied 809 age and
sex matched suspected cases of hypothyroidism and observed that mean TSH in blacks were significantly lower
compared to whites [29]. This study inferred that racial parameter contributed to 6.5% variation in TSH levels. Olmos
et al. in the ELSA-Brazil (Brazilian longitudinal study on
adult health) study observed higher prevalence of overt
hypothyroidism in whites, compared to brown and black

population [30]. It signifies that brown and black ethnicity
may have a protective effect from developing overt
hypothyroidism. We also observed that a significant number
of participants belonged to the highest income strata and
majority had good education. This suggests that hypothyroid
participants have the potential to comprehend the impact of
the illness and take the necessary steps for effective treatment of the ailment. Similar findings were observed by
Olmos et al. in their Brazilian population, where most of the
hypothyroid subjects taking levothyroxine belonged to the
high socioeconomic strata [30]. About 92% of hypothyroid
participants in our study had health insurance coverages
which could cover the medication cost.
In our study, lifestyle characteristics of participants
showed that they had lower levels of physical activity
and consumed alcohol, though majority of them never
smoked. Ciloglu et al. reported that increased physical
activity at the anaerobic threshold steadily increased the
production of TSH, fT4, and T4 but produced a fall in
total T3 and fT3 [31]. Thus, regular aerobic exercises
may be beneficial in normal subjects to boost endogenous thyroid hormone synthesis. Bansal et al. reported
that regular exercise could have a beneficial effect on the
thyroid hormone status of hypothyroid subjects on treatment [32]. In our study, a significant majority of
hypothyroid participants consumed alcohol. It is essential to note that alcohol has a negative effect over the
thyroid function. Alcohol reduces the levels of peripheral
thyroid hormones especially during late alcohol withdrawal and can aggravate hypothyroidism [33, 34]. Thus,
abstinence from alcohol should be advised for patients
diagnosed with hypothyroidism and who are on thyroid
medications.

Table 4 Correlation between variables included in the regression models
1
1. Age

2

3

4

5

6

7

8

9

10

11

12

13

14

15

–

2. Education

0.152

–

3. Income

0.250

0.243

–

4. Smoking

0.187

0.015

0.163

–

5. Alcohol consumption

0.224

0.197

0.159

0.229

–

6. Body mass index

0.250

0.200

0.123

0.462

0.476

–

7. Physical activity

0.552

0.063

0.116

0.044

0.167

0.352

–

8. Hypertension

0.091

0.293

0.254

0.368

0.018

0.478

0.284

–

9. Diabetes

0.187

0.187

0.247

0.260

0.169

0.167

0.173

0.142

–

10. Dyslipidemia

0.398

0.232

0.317

0.457

0.145

0.196

0.084

0.140

0.122

–

11. Blood urea nitrogen

0.407

0.180

0.318

0.343

0.354

0.168

0.374

0.213

0.184

0.243

–

12. Creatinine

0.351

0.246

0.169

0.107

0.342

0.182

0.486

0.752

0.388

0.105

0.203

–

13. Magnesium

0.080

0.309

0.451

0.188

0.415

0.106

0.239

0.093

0.364

0.114

0.327

0.117

–

14. Vitamin D

0.166

0.425

0.179

0.302

0.341

0.040

0.327

0.143

0.499

0.440

0.305

0.302

0.341

–

15. Hypothyroidism

0.370

0.128

0.167

0.135

0.167

0.098

0.156

0.228

0.167

0.222

0.470

0.344

0.086

0.355

–

Appunni et al. BMC Endocrine Disorders

(2021) 21:224

Vitamin D levels could be influenced by whether the
physical activity is performed indoors or outdoors. Similarly, it could also be influenced by alcohol consumptions, which significantly increases vitamin D levels.
Although, participants in our study reported lower levels
of physical activity and alcohol consumption, there were
no interaction of these variables with the relationship
between vitamin D status and hypothyroidism.
Vitamin D deficiency is being recognized as a global
pandemic most presumably due to heliophobia of the
general population, especially among those residing in
southeast Asia [35]. Thus, endocrinologist in such countries have recommended to increase the recommended
daily allowance (RDA) for vitamin D to prevent deficiency states. Huotari and Herzig in their literature review on vitamin D status in populations living in higher
latitudes recommended that vitamin D deficiency was
highly predominant in the winter season and consumption of vitamin D fortified foods and supplements would
be necessary to prevent deficiency states in these seasons
[36]. Parva et al. using NHANES found that the prevalence of vitamin D deficiency was as high as 39% in the
US population [37]. They also found out that the odds
of having vitamin D deficiency were higher among black
race and individuals with poor health and obesity. One
of the key clinical condition observed in vitamin D deficiency was the increased incidence of autoimmune diseases [16]. Hypothyroidism is commonly a disease
resulting from similar autoimmune insults as indicated
by higher anti-peroxidase and anti-thyroglobulin antibodies [12, 13].
We found that participants having deficient vitamin D
levels were significantly higher among hypothyroid participants, compared to normal controls. Conversely, participants with optimal vitamin D levels were significantly
higher in control group, compared to hypothyroid participants. In a nutshell, 63.7% of the hypothyroid participants has sub-optimal levels of vitamin D as compared
to controls (53.3%). This shows that prevalence of low
vitamin D levels could be associated with increased risk
of developing hypothyroidism, though we could not establish a causal relationship. Mackawy et al. in a small
sample size of 30 subjects observed that vitamin D
deficiency is associated with lower thyroid levels [25].
In our study, we found that the odds of developing
hypothyroidism were significantly higher among patients
with intermediate and deficient levels of vitamin D.
Kim38 reported in Korean population that vitamin D deficiency is highly prevalent in autoimmune Hashimoto’s
thyroiditis presenting with overt hypothyroidism than
subclinical hypothyroid variants [38]. Studies have
shown that a reciprocal relationship exists between
serum TSH and vitamin D levels in hypothyroid subjects
[38, 39]. ElRawi et al. reported vitamin D deficient

Page 7 of 9

hypothyroid subjects have higher insulin resistance
which significantly correlated with higher anti-thyroid
antibodies, anti-TPO and anti-Tg [39]. However, they
did not observe any significant vitamin D receptor polymorphism in subject vs control suggesting that correction with vitamin D supplements may possibly have a
therapeutic benefit in correcting thyroid status. Talaei
et al. found that supplementation of 50,000 IU vitamin D
to hypothyroid subject lowered TSH and parathormone
levels without any significant effect over serum thyroxine
(T3 and T4) levels [40]. In another scenario, Ucan et al.
observed that a similar vitamin D oral supplementation
to autoimmune Hashimoto’s thyroiditis subjects significantly improved thyroid status concurrent with a decrease in autoimmune antibodies and an increase in free
T4 (fT4) levels [41]. Mirhosseini et al. in a large cohort
found that a significant fraction of subjects had an improvement in their thyroid status following vitamin D
supplementation [42]. A randomized control trial by
Chahardoli et al. found that vitamin D supplementation
significantly reduced the levels of tropic hormone TSH
and anti-Tg antibodies [43]. However, this study did not
find any significant differences with respect to anti-TPO
levels and thyroxine levels between the groups. These
finding suggest that vitamin D has a key role in regulating both the thyroid destroying autoimmune antibodies
as well as the pituitary trophic hormone TSH. In another
study, thyroidectomy in the past as well as subjects receiving thyroid supplementation therapy had higher vitamin D levels, compared to undertreated patients [44].
This suggest that undertreated hypothyroidism and progressive autoimmune inflammation mediated destruction
of thyroid could have detrimental effect over vitamin D
metabolism and could potentiate the systemic ill-health
effects associated with thyroid dysfunction. Metaanalysis and case control study-based observations show
that individuals with low vitamin D levels also have an
increased risk of developing thyroid cancer [45].
In our study, we found a significant association between body mass index and hypothyroid state. Obesity
or increased fat deposition is another risk factor for low
vitamin D levels. Steroid derived hormones like vitamin
D tend to get redistributed in the adipose tissue which
function as a huge reservoir [46]. This results in a lower
plasma level of circulating pre-vitamin D resulting in
vitamin D deficiencies. Liel et al. reported low levels of
circulating vitamin D in obese subjects compared to
non-obese [47]. Vitamin D deficient hypothyroid patients also show an increased likelihood for developing
diabetes mellitus, hypertension and anemia [48]. McGill
et al. reported that vitamin D levels fall by 0.29 nmol/L
for every centimeter increase in waist circumference due
to abdominal obesity [49]. Hypothyroidism due to autoimmune destruction is highly associated with centripetal
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obesity with metabolic derangements where both antiTPO and anti-Tg positively correlate with serum triglyceride levels and waist circumference [50]. Our study
also show that hypothyroid subjects had significantly increased prevalence of diabetes mellitus, hypertension
and dyslipidemia thus qualifying for metabolic syndrome. This suggest that metabolic alterations associated
with hypothyroidism could be plausibly aggravated by
vitamin D deficiency.
We used NHANES, which is a nationally representative
data set. Because of the large sample size, we could make
better estimates of the relationship between vitamin D
and hypothyroidism. Therefore, our results would be
generalizable to the entire U.S. population thereby assuring high levels of external validity. Most of the variables in
our study are based on laboratory results. Hence, we could
assure greater levels of internal validity of our results. Our
study has some limitations. Since this study is crosssectional, we could not infer causality in the association
between vitamin D and hypothyroidism. In addition, we
also excluded missing data which could have led to some
confounding in the results. Due to the limitations NHAN
ES data certain important variables related to vitamin D
such as indoor versus outdoor physical activity, seasonal
changes, and geographical coordinates could not be ascertained and could have led to some biases. Pathological
conditions such as non-alcoholic fatty liver disease which
could affect vitamin D also could not be determined.
Some of the variables collected in the study such as smoking status, alcohol consumption, and physical activity,
were self-reported and therefore susceptible to social desirability bias. Though we tried our best to account for potential confounders and covariates some residual
confounders could still affect the findings in our study.

Conclusion
Our study highlights the association between vitamin D
deficiency and hypothyroidism using a large nationally
representative data. Future largescale experimental studies are needed to confirm the findings in our study.
Based on the findings of our study, healthcare initiatives
such as mass vitamin D deficiency screening among atrisk population such as elderly, obese, indoor and sedentary individuals and prompt treatment with dietary supplementations could significantly decrease the risk for
hypothyroidism in the long-term.
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